Integer Holdings Corporation $ITGR Position Reduced by Deutsche Bank AG

Deutsche Bank AG reduced its holdings in Integer Holdings Corporation (NYSE:ITGR) by 9.1% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 26,716 shares of the medical equipment provider’s stock after selling 2,665 shares during the quarter. Deutsche Bank AG owned approximately 0.08% of Integer worth $3,153,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of ITGR. Vaughan Nelson Investment Management L.P. bought a new position in shares of Integer in the 1st quarter worth about $33,337,000. Capital Research Global Investors lifted its position in shares of Integer by 16.0% in the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider’s stock worth $186,960,000 after buying an additional 194,895 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Integer by 8,697.6% in the 1st quarter. GAMMA Investing LLC now owns 78,123 shares of the medical equipment provider’s stock worth $92,190,000 after buying an additional 77,235 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Integer in the 4th quarter worth about $7,889,000. Finally, Northern Trust Corp lifted its position in shares of Integer by 14.2% in the 4th quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider’s stock worth $55,974,000 after buying an additional 52,556 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Stock Performance

NYSE:ITGR opened at $105.61 on Tuesday. Integer Holdings Corporation has a twelve month low of $104.93 and a twelve month high of $146.36. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72. The company has a 50-day moving average of $114.73 and a 200-day moving average of $119.79. The firm has a market cap of $3.70 billion, a price-to-earnings ratio of 46.52, a price-to-earnings-growth ratio of 0.84 and a beta of 1.02.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The business had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. During the same quarter last year, the business posted $1.30 EPS. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. Analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

ITGR has been the topic of a number of recent research reports. Wall Street Zen upgraded shares of Integer from a “sell” rating to a “hold” rating in a research report on Monday, May 19th. Citigroup raised shares of Integer from a “hold” rating to a “strong-buy” rating and increased their price objective for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Truist Financial dropped their price objective on shares of Integer from $145.00 to $137.00 and set a “buy” rating on the stock in a report on Friday, July 25th. KeyCorp dropped their price objective on shares of Integer from $154.00 to $145.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Finally, Benchmark dropped their price objective on shares of Integer from $150.00 to $140.00 and set a “buy” rating on the stock in a report on Friday, April 25th. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $140.25.

Insider Activity

In other news, Director Donald J. Spence sold 14,739 shares of the firm’s stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the transaction, the director owned 18,781 shares in the company, valued at approximately $2,260,856.78. This trade represents a 43.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Martin C. Maxwell sold 8,720 shares of the firm’s stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director owned 22,170 shares of the company’s stock, valued at approximately $2,672,815.20. The trade was a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.16% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.